CML cells were transfected with sh-RNA of HNRNPH1 or sh-Con and then treated with different concentrations of imatinib to investigate the effect of HNRNPH1 on imatinib sensitivity. Here, HNRNPH1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.